UB Paderborn / Katalog / Suche / in CDI

Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial

Nicotine & tobacco research, 2021-08, Vol.23 (10), p.1682-1690

2021

Link zum Volltext

Verfügbarkeit prüfen

Repeated Δ9-Tetrahydrocannabinol Exposure in Adolescent Monkeys: Persistent Effects Selective for Spatial Working Memory

The American journal of psychiatry, 2014-04, Vol.171 (4), p.416-425

2014

Link zum Volltext

Verfügbarkeit prüfen

MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment

Psychopharmacology, 2007-01, Vol.189 (4), p.489-503

2007

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder

Neuropsychopharmacology (New York, N.Y.), 2010-09, Vol.35 (10), p.2060-2071

2010

Link zum Volltext

Verfügbarkeit prüfen

A randomized trial of safety and pharmacodynamic interactions between a selective glucocorticoid receptor antagonist, PT150, and ethanol in healthy volunteers

Scientific reports, 2021-05, Vol.11 (1), p.9876-9876, Article 9876

2021

Link zum Volltext

Verfügbarkeit prüfen

The prevalence, metabolic disturbances and clinical correlates of recent suicide attempts in Chinese inpatients with major depressive disorder

BMC psychiatry, 2019-05, Vol.19 (1), p.144-144, Article 144

2019

Link zum Volltext

Verfügbarkeit prüfen

Suicidal behaviors and attention deficit hyperactivity disorder (ADHD): a cross-sectional study among Chinese medical college students

BMC psychiatry, 2021-05, Vol.21 (1), p.258-258, Article 258

2021

Link zum Volltext

Verfügbarkeit prüfen

Exenatide as an adjunct to nicotine patch for smoking cessation and prevention of postcessation weight gain among treatment-seeking smokers with pre-diabetes and/or overweight: study protocol for a randomised, placebo-controlled clinical trial

BMJ open, 2023-06, Vol.13 (6), p.e072707-e072707

2023

Link zum Volltext

Verfügbarkeit prüfen

Neurocognitive Correlates of Cerebellar Volumetric Alterations in Youth with Pediatric Bipolar Spectrum Disorders and Bipolar Offspring

Current neuropharmacology, 2023-01, Vol.21 (6), p.1367-1378

2023

Link zum Volltext

Verfügbarkeit prüfen

Cortical Correlates of Impulsive Aggressive Behavior in Pediatric Bipolar Disorder

Frontiers in psychiatry, 2021-07, Vol.12, p.674707-674707

2021

Link zum Volltext

Verfügbarkeit prüfen

Endocannabinoid metabolism in the prefrontal cortex in schizophrenia

Schizophrenia research, 2013-06, Vol.147 (1), p.53-57

2013

Link zum Volltext

Verfügbarkeit prüfen

Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study

The international journal of neuropsychopharmacology, 2016-07, Vol.19 (7), p.pyw029

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications

Expert opinion on investigational drugs, 2013-12, Vol.22 (12), p.1549-1568

2013

Link zum Volltext

Verfügbarkeit prüfen

Psychosis and synthetic cannabinoids

Psychiatry research, 2018-10, Vol.268, p.400-412

2018

Link zum Volltext

Verfügbarkeit prüfen

Primate trace amine receptor 1 modulation by the dopamine transporter

The Journal of pharmacology and experimental therapeutics, 2005-06, Vol.313 (3), p.983

2005

Link zum Volltext

Verfügbarkeit prüfen

6.135 EVALUATION OF BORDERLINE FEATURES IN YOUTH WITH BIPOLAR DISORDER

Journal of the American Academy of Child and Adolescent Psychiatry, 2016-10, Vol.55 (10), p.S247-S247

2016

Link zum Volltext

Verfügbarkeit prüfen

Cognitive correlates of impulsive aggression in youth with pediatric bipolar disorder and bipolar offspring

Journal of affective disorders, 2021-05, Vol.287, p.387-396

2021

Link zum Volltext

Verfügbarkeit prüfen

Neurocircuitry basis of the opioid use disorder–post-traumatic stress disorder comorbid state: conceptual analyses using a dimensional framework

The Lancet. Psychiatry, 2022-01, Vol.9 (1), p.84-96

2022

Link zum Volltext

Verfügbarkeit prüfen

Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys

Journal of psychopharmacology (Oxford), 2020-02, Vol.34 (2), p.211-220

2020

Link zum Volltext

Verfügbarkeit prüfen

Continuing the conversation around opioid use disorder and post-traumatic stress disorder comorbidity

The Lancet. Psychiatry, 2022-08, Vol.9 (8), p.e37-e38

2022

Link zum Volltext

Verfügbarkeit prüfen

Comorbid alcohol use and post-traumatic stress disorders: Pharmacotherapy with aldehyde dehydrogenase 2 inhibitors versus current agents

Progress in neuro-psychopharmacology & biological psychiatry, 2022-04, Vol.115, p.110506, Article 110506

2022

Link zum Volltext

Verfügbarkeit prüfen

Subtherapeutic Acetazolamide Doses as a Noninvasive Method for Assessing Medication Adherence

Clinical pharmacology and therapeutics, 2020-12, Vol.108 (6), p.1203-1212

2020

Link zum Volltext

Verfügbarkeit prüfen

Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial

The journal of clinical psychiatry, 2016-05, Vol.77 (5), p.e561

2016

Link zum Volltext

Verfügbarkeit prüfen

A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders

Journal of psychopharmacology (Oxford), 2015-01, Vol.29 (1), p.50-56

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical Management of Cannabis Complications

The Psychiatric times, 2021-03, Vol.38 (3), p.17

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial

Repeated Δ9-Tetrahydrocannabinol Exposure in Adolescent Monkeys: Persistent Effects Selective for Spatial Working Memory

MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment

Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder

A randomized trial of safety and pharmacodynamic interactions between a selective glucocorticoid receptor antagonist, PT150, and ethanol in healthy volunteers

The prevalence, metabolic disturbances and clinical correlates of recent suicide attempts in Chinese inpatients with major depressive disorder

Suicidal behaviors and attention deficit hyperactivity disorder (ADHD): a cross-sectional study among Chinese medical college students

Exenatide as an adjunct to nicotine patch for smoking cessation and prevention of postcessation weight gain among treatment-seeking smokers with pre-diabetes and/or overweight: study protocol for a randomised, placebo-controlled clinical trial

Neurocognitive Correlates of Cerebellar Volumetric Alterations in Youth with Pediatric Bipolar Spectrum Disorders and Bipolar Offspring

Cortical Correlates of Impulsive Aggressive Behavior in Pediatric Bipolar Disorder

Endocannabinoid metabolism in the prefrontal cortex in schizophrenia

Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study

Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications

Psychosis and synthetic cannabinoids

Primate trace amine receptor 1 modulation by the dopamine transporter

6.135 EVALUATION OF BORDERLINE FEATURES IN YOUTH WITH BIPOLAR DISORDER

Cognitive correlates of impulsive aggression in youth with pediatric bipolar disorder and bipolar offspring

Neurocircuitry basis of the opioid use disorder–post-traumatic stress disorder comorbid state: conceptual analyses using a dimensional framework

Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys

Continuing the conversation around opioid use disorder and post-traumatic stress disorder comorbidity

Comorbid alcohol use and post-traumatic stress disorders: Pharmacotherapy with aldehyde dehydrogenase 2 inhibitors versus current agents

Subtherapeutic Acetazolamide Doses as a Noninvasive Method for Assessing Medication Adherence

Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial

A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders

Clinical Management of Cannabis Complications

Suchergebnisse filtern